CENTURY ALUMINUM COMPANY (CENX)

US1564311082 - Common Stock

10.25  -0.35 (-3.3%)

After market: 10.28 +0.03 (+0.29%)

Fundamental Rating

2

Overall CENX gets a fundamental rating of 2 out of 10. We evaluated CENX against 156 industry peers in the Metals & Mining industry. CENX has a bad profitability rating. Also its financial health evaluation is rather negative. CENX is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

In the past year CENX has reported negative net income.
CENX had a positive operating cash flow in the past year.
In the past 5 years CENX always reported negative net income.
In multiple years CENX reported negative operating cash flow during the last 5 years.

1.2 Ratios

CENX has a Return On Assets of -10.28%. This is in the lower half of the industry: CENX underperforms 73.08% of its industry peers.
CENX has a Return On Equity of -54.29%. This is amonst the worse of the industry: CENX underperforms 87.18% of its industry peers.
Industry RankSector Rank
ROA -10.28%
ROE -54.29%
ROIC N/A
ROA(3y)-6.8%
ROA(5y)-6.02%
ROE(3y)-21.93%
ROE(5y)-17.29%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CENX's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 1.50%, CENX is doing worse than 64.74% of the companies in the same industry.
CENX's Gross Margin has declined in the last couple of years.
CENX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1.5%
OM growth 3YN/A
OM growth 5Y-43.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-27.27%

1

2. Health

2.1 Basic Checks

CENX does not have a ROIC to compare to the WACC, probably because it is not profitable.
CENX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of 0.01, we must say that CENX is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.01, CENX is not doing good in the industry: 80.77% of the companies in the same industry are doing better.
CENX has a Debt/Equity ratio of 1.31. This is a high value indicating a heavy dependency on external financing.
CENX has a worse Debt to Equity ratio (1.31) than 91.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF N/A
Altman-Z 0.01
ROIC/WACCN/A
WACC8.02%

2.3 Liquidity

A Current Ratio of 1.08 indicates that CENX should not have too much problems paying its short term obligations.
With a Current ratio value of 1.08, CENX is not doing good in the industry: 89.74% of the companies in the same industry are doing better.
A Quick Ratio of 0.34 indicates that CENX may have some problems paying its short term obligations.
With a Quick ratio value of 0.34, CENX is not doing good in the industry: 93.59% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 0.34

3

3. Growth

3.1 Past

CENX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -154.17%.
The Earnings Per Share has been decreasing by -8.29% on average over the past years.
The Revenue for CENX has decreased by -24.20% in the past year. This is quite bad
Measured over the past years, CENX shows a quite strong growth in Revenue. The Revenue has been growing by 11.81% on average per year.
EPS 1Y (TTM)-154.17%
EPS 3YN/A
EPS 5Y-8.29%
EPS growth Q2Q61.76%
Revenue 1Y (TTM)-24.2%
Revenue growth 3Y14.78%
Revenue growth 5Y11.81%
Revenue growth Q2Q-14.44%

3.2 Future

CENX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 80.19% yearly.
Based on estimates for the next years, CENX will show a decrease in Revenue. The Revenue will decrease by -6.94% on average per year.
EPS Next Y21.13%
EPS Next 2Y50.55%
EPS Next 3Y80.19%
EPS Next 5YN/A
Revenue Next Year-22.83%
Revenue Next 2Y-14.71%
Revenue Next 3Y-6.94%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CENX. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 18.84 indicates a rather expensive valuation of CENX.
CENX's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 21.63. CENX is around the same levels.
Industry RankSector Rank
PE N/A
Fwd PE 18.84

4.2 Price Multiples

CENX's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 31.89

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CENX's earnings are expected to grow with 80.19% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.55%
EPS Next 3Y80.19%

0

5. Dividend

5.1 Amount

CENX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CENTURY ALUMINUM COMPANY

NASDAQ:CENX (2/22/2024, 7:00:00 PM)

After market: 10.28 +0.03 (+0.29%)

10.25

-0.35 (-3.3%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap947.10M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 18.84
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.28%
ROE -54.29%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 1.5%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.08
Quick Ratio 0.34
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-154.17%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y21.13%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-24.2%
Revenue growth 3Y14.78%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y